{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:39:45Z","timestamp":1785220785284,"version":"3.55.0"},"reference-count":105,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":74,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1111\/bjd.13681","type":"journal-article","created":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T12:33:58Z","timestamp":1422362038000},"page":"37-46","source":"Crossref","is-referenced-by-count":34,"special_numbering":"supplement S1","title":["Is hormonal treatment still an option in acne today?"],"prefix":"10.1093","volume":"172","author":[{"given":"V.","family":"Bettoli","sequence":"first","affiliation":[{"name":"Department of Medical Sciences; Section of Dermatology; University of Ferrara; Azienda Ospedaliero-Universitaria di Ferrara; via Aldo Moro, 8 44124 Cona Ferrara Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Zauli","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences; Section of Dermatology; University of Ferrara; Azienda Ospedaliero-Universitaria di Ferrara; via Aldo Moro, 8 44124 Cona Ferrara Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Virgili","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences; Section of Dermatology; University of Ferrara; Azienda Ospedaliero-Universitaria di Ferrara; via Aldo Moro, 8 44124 Cona Ferrara Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,6,19]]},"reference":[{"key":"10.1111\/bjd.13681-BIB0001|bjd13681-cit-0001","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaad.2009.01.019","article-title":"New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group","volume":"60","author":"Thiboutot","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13681-BIB0002|bjd13681-cit-0002","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1067\/mjd.2003.618","article-title":"Management of acne","volume":"49","author":"Gollnick","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13681-BIB0003|bjd13681-cit-0003","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaad.2006.08.048","article-title":"Guidelines of care for acne vulgaris management","volume":"56","author":"Strauss","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13681-BIB0004|bjd13681-cit-0004","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clindermatol.2009.03.006","article-title":"Hormonal therapy for acne: why not as first line therapy? Facts and controversies","volume":"28","author":"Katsambas","year":"2010","journal-title":"Clin Dermatol"},{"key":"10.1111\/bjd.13681-BIB0005|bjd13681-cit-0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0019-5154.127667","article-title":"Profiling and hormonal therapy for acne in women","volume":"59","author":"Ghosh","year":"2014","journal-title":"Indian J Dermatol"},{"key":"10.1111\/bjd.13681-BIB0006|bjd13681-cit-0006","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4103\/0378-6323.110765","article-title":"Hormone therapy in acne","volume":"79","author":"Lakshmi","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"Suppl. 1","key":"10.1111\/bjd.13681-BIB0007|bjd13681-cit-0007","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bjd.13634","article-title":"What's new in the physiopathology of acne?","volume":"172","author":"Suh","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13681-BIB0008|bjd13681-cit-0008","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00403-012-1265-x","article-title":"The role of androgen and androgen receptor in the skin-related disorders","volume":"304","author":"Lai","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/bjd.13681-BIB0009|bjd13681-cit-0009","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/bjd.13681-BIB0010|bjd13681-cit-0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/1523-1747.ep12539043","article-title":"Plasma androgens in women with acne vulgaris","volume":"81","author":"Lucky","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13681-BIB0011|bjd13681-cit-0011","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2230.1984.tb00751.x","article-title":"Androgen status in women with late onset or persistent acne vulgaris","volume":"9","author":"Darley","year":"1984","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.13681-BIB0012|bjd13681-cit-0012","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.0926-9959.2001.00014.x","article-title":"Endocrinological evaluation and hormonal therapy for women with difficult acne","volume":"15","author":"Thiboutot","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13681-BIB0013|bjd13681-cit-0013","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2133.1989.tb08208.x","article-title":"Most women with acne have polycystic ovaries","volume":"121","author":"Bunker","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13681-BIB0014|bjd13681-cit-0014","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12098-013-1203-8","article-title":"Cushing syndrome","volume":"81","author":"Bista","year":"2014","journal-title":"Indian J Pediatr"},{"key":"10.1111\/bjd.13681-BIB0015|bjd13681-cit-0015","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.mcna.2009.08.008","article-title":"Acne and systemic disease","volume":"93","author":"Lolis","year":"2009","journal-title":"Med Clin North Am"},{"key":"10.1111\/bjd.13681-BIB0016|bjd13681-cit-0016","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.13681-BIB0017|bjd13681-cit-0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0004563214529748","article-title":"17-hydroxyprogesterone in children, adolescents and adults","volume":"51","author":"Honour","year":"2014","journal-title":"Ann Clin Biochem"},{"key":"10.1111\/bjd.13681-BIB0018|bjd13681-cit-0018","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0015-0282(99)00383-0","article-title":"Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study","volume":"72","author":"Azziz","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1111\/bjd.13681-BIB0019|bjd13681-cit-0019","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1523-1747.2002.00613.x","article-title":"Cutaneous androgen metabolism: basic research and clinical prospectives","volume":"119","author":"Chen","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13681-BIB0020|bjd13681-cit-0020","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1046\/j.1523-1747.2003.12244.x","article-title":"Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in the epidermis, normal sebocytes and an immortalized sebocyte cell line (SEB-1)","volume":"120","author":"Thiboutot","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13681-BIB0021|bjd13681-cit-0021","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2133.1997.tb14889.x","article-title":"Activity of type 1 5-alpha reductase is greater in the follicular infrainfundibulum compared with the epidermis","volume":"136","author":"Thiboutot","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13681-BIB0022|bjd13681-cit-0022","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jsbmb.2014.05.004","article-title":"Transcriptional control of local estrogen formation by aromatase in the breast","volume":"145C","author":"To","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1111\/bjd.13681-BIB0023|bjd13681-cit-0023","doi-asserted-by":"crossref","first-page":"858176","DOI":"10.1155\/2010\/858176","article-title":"Lipid mediators in acne","volume":"2010","author":"Ottaviani","year":"2010","journal-title":"Mediators Inflamm"},{"key":"10.1111\/bjd.13681-BIB0024|bjd13681-cit-0024","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1473-2165.2009.00437.x","article-title":"Accumulation of lipid peroxide in the content of comedones may be involved in the progression of comedogenesis and inflammatory changes in comedones","volume":"8","author":"Tochio","year":"2009","journal-title":"J Cosmet Dermatol"},{"key":"10.1111\/bjd.13681-BIB0025|bjd13681-cit-0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/00365513.2014.936676","article-title":"Polycystic ovary syndrome: metabolic consequences and long-term management","volume":"74","author":"Carmina","year":"2014","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1111\/bjd.13681-BIB0026|bjd13681-cit-0026","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jaad.2012.11.018","article-title":"Contraception and the dermatologist","volume":"68","author":"Tyler","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13681-BIB0027|bjd13681-cit-0027","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.clindermatol.2004.03.010","article-title":"Acne: hormonal concepts and therapy","volume":"22","author":"Thiboutot","year":"2004","journal-title":"Clin Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/bjd.13681-BIB0028|bjd13681-cit-0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2011.04374.x","article-title":"European evidence-based (S3) guidelines for the treatment of acne","volume":"26","author":"Nast","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13681-BIB0029|bjd13681-cit-0029","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJMcp033487","article-title":"Clinical practice. Acne","volume":"352","author":"James","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.13681-BIB0030|bjd13681-cit-0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000067823","article-title":"Update and future of hormonal therapy in acne","volume":"206","author":"Thiboutot","year":"2003","journal-title":"Dermatology"},{"issue":"Suppl","key":"10.1111\/bjd.13681-BIB0031|bjd13681-cit-0031","first-page":"S3","article-title":"Contraceptive redesign: new progestins\/new regimens","author":"Sulak","year":"2004","journal-title":"J Fam Pract"},{"key":"10.1111\/bjd.13681-BIB0032|bjd13681-cit-0032","first-page":"69","article-title":"Examining the use of oral contraceptives in the management of acne","volume":"2","author":"Salvaggio","year":"2010","journal-title":"Int J Womens Health"},{"key":"10.1111\/bjd.13681-BIB0033|bjd13681-cit-0033","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0733-8635(05)70147-9","article-title":"Acne and rosacea: new and emerging therapies","volume":"18","author":"Thiboutot","year":"2000","journal-title":"Dermatol Clin"},{"issue":"Suppl. 11","key":"10.1111\/bjd.13681-BIB0034|bjd13681-cit-0034","first-page":"975","article-title":"Evolution of progestins. Focus on the novel progestin drospirenone","volume":"47","author":"Thorneycroft","year":"2002","journal-title":"J Reprod Med"},{"key":"10.1111\/bjd.13681-BIB0035|bjd13681-cit-0035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/humrep\/deg090","article-title":"Differences in the use of combined contraceptives amongst women with and without acne","volume":"18","author":"Seaman","year":"2003","journal-title":"Hum Reprod"},{"issue":"Suppl. 1","key":"10.1111\/bjd.13681-BIB0036|bjd13681-cit-0036","first-page":"8","article-title":"Pharmacology of hormonal contraceptives and acne","volume":"81","author":"O'Connel","year":"2008","journal-title":"Cutis"},{"key":"10.1111\/bjd.13681-BIB0037|bjd13681-cit-0037","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaad.2009.12.002","article-title":"Hormone therapy for acne","volume":"62","author":"Junkins-Hopkins","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13681-BIB0038|bjd13681-cit-0038","first-page":"CD004425","article-title":"Combined oral contraceptive pill for treatment of acne","volume":"7","author":"Arowojolu","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/bjd.13681-BIB0039|bjd13681-cit-0039","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0015-0282(01)01938-0","article-title":"A randomized, controlled trial of a low-dose contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment","volume":"76","author":"Thiboutot","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1111\/bjd.13681-BIB0040|bjd13681-cit-0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1067\/mjd.2002.122192","article-title":"Efficacy of a low-dose oral contraceptive containing 20 \u03bcg of ethinylestradiol and 100 \u03bcg of levonorgestrel for the treatment of moderate acne: a randomized, placebo-controlled trial","volume":"47","author":"Leyden","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13681-BIB0041|bjd13681-cit-0041","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/cjwh.2001.25638","article-title":"Use of a low-dose oral contraceptive containing norethindrone acetate and ethinyl estradiol in the treatment of moderate acne vulgaris","volume":"1","author":"Maloney","year":"2001","journal-title":"Clin J Women's Health"},{"key":"10.1111\/bjd.13681-BIB0042|bjd13681-cit-0042","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0190-9622(97)70112-9","article-title":"Effectiveness of norgestimate and ethinylestradiol in treating moderate acne vulgaris","volume":"37","author":"Lucky","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13681-BIB0043|bjd13681-cit-0043","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0029-7844(97)00059-8","article-title":"Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial","volume":"89","author":"Redmond","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1111\/bjd.13681-BIB0044|bjd13681-cit-0044","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/AOG.0b013e318187e1c5","article-title":"Treatment of acne using a 3- milligram drospirenone\/20-microgram ethinyl estradiol oral contraceptive administered in a 24\/4 regimen: a randomized controlled trial","volume":"112","author":"Maloney","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1111\/bjd.13681-BIB0045|bjd13681-cit-0045","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.contraception.2008.10.010","article-title":"Efficacy of a combined oral contraceptive containing 0.030\u00a0mg ethinylestradiol\/2\u00a0mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035\u00a0mg ethinylestradiol\/2\u00a0mg cyproterone acetate","volume":"79","author":"Palumbo-Kinne","year":"2009","journal-title":"Contraception"},{"key":"10.1111\/bjd.13681-BIB0046|bjd13681-cit-0046","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.contraception.2009.02.016","article-title":"Efficacy of an oral contraceptive containing EE 0.03\u00a0mg and CMA 2\u00a0mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial","volume":"80","author":"Plewig","year":"2009","journal-title":"Contraception"},{"issue":"Suppl. 4","key":"10.1111\/bjd.13681-BIB0047|bjd13681-cit-0047","first-page":"2","article-title":"The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhoea","volume":"69","author":"Vloten","year":"2002","journal-title":"Cutis"},{"key":"10.1111\/bjd.13681-BIB0048|bjd13681-cit-0048","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/11535450-000000000-00000","article-title":"Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicenter study","volume":"30","author":"Kelly","year":"2010","journal-title":"Clin Drug Investig"},{"key":"10.1111\/bjd.13681-BIB0049|bjd13681-cit-0049","first-page":"123","article-title":"Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment","volume":"74","author":"Thorneycroft","year":"2004","journal-title":"Cutis"},{"key":"10.1111\/bjd.13681-BIB0050|bjd13681-cit-0050","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/13625187.2011.614029","article-title":"Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17-beta-oestradiol in a 24\/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21\/7 regimen","volume":"16","author":"Mansour","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1111\/bjd.13681-BIB0051|bjd13681-cit-0051","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/ejc.6.1.46.53","article-title":"Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate","volume":"6","author":"Vartiainen","year":"2001","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1111\/bjd.13681-BIB0052|bjd13681-cit-0052","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0010-7824(94)90024-8","article-title":"The effect of CTR-24, a biphasic oral contraceptive combination, compared to Diane-35 in women with acne","volume":"50","author":"Dieben","year":"1994","journal-title":"Contraception"},{"key":"10.1111\/bjd.13681-BIB0053|bjd13681-cit-0053","first-page":"423","article-title":"Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate","volume":"41","author":"Charoenvisal","year":"1996","journal-title":"Int J Fertil Menopausal Stud"},{"key":"10.1111\/bjd.13681-BIB0054|bjd13681-cit-0054","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0010-7824(95)00037-B","article-title":"Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women","volume":"51","author":"Koetvsawang","year":"1995","journal-title":"Contraception"},{"key":"10.1111\/bjd.13681-BIB0055|bjd13681-cit-0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/13625189809051413","article-title":"Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene","volume":"3","author":"Halbe","year":"1998","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1111\/bjd.13681-BIB0056|bjd13681-cit-0056","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0010-7824(96)00005-4","article-title":"Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris","volume":"53","author":"Mango","year":"1996","journal-title":"Contraception"},{"key":"10.1111\/bjd.13681-BIB0057|bjd13681-cit-0057","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000051701","article-title":"Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE\/CMA (Belara) and EE\/LNG (Microgynon)","volume":"203","author":"Worret","year":"2001","journal-title":"Dermatology"},{"key":"10.1111\/bjd.13681-BIB0058|bjd13681-cit-0058","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/00016348609157049","article-title":"Cyproterone acetate versus levonorgestrel combined with ethinylestradiol in the treatment of acne. Results of a multicenter study","volume":"134","author":"Carlborg","year":"1986","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1111\/bjd.13681-BIB0059|bjd13681-cit-0059","first-page":"1922","article-title":"Therapy of androgenization symptoms: double blind study of an antiandrogen preparation (SH B 209 AB) against neogynon","volume":"72","author":"Lachnit-Fixon","year":"1977","journal-title":"Med Klin"},{"key":"10.1111\/bjd.13681-BIB0060|bjd13681-cit-0060","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2340\/0001555564517523","article-title":"Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives","volume":"64","author":"Palatsi","year":"1984","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.13681-BIB0061|bjd13681-cit-0061","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1067\/mob.2003.294","article-title":"A randomized controlled trial of second- versus third-generation oral contraceptives in the treatment of acne vulgaris","volume":"188","author":"Rosen","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/bjd.13681-BIB0062|bjd13681-cit-0062","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.contraception.2003.12.017","article-title":"Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 microg ethinylestradiol","volume":"69","author":"Winkler","year":"2004","journal-title":"Contraception"},{"key":"10.1111\/bjd.13681-BIB0063|bjd13681-cit-0063","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0010-7824(99)00093-1","article-title":"Effect of low-dose oral contraceptives on androgenic markers and acne","volume":"60","author":"Thorneycroft","year":"1999","journal-title":"Contraception"},{"key":"10.1111\/bjd.13681-BIB0064|bjd13681-cit-0064","unstructured":"Johnson & Johnson Taiwan Ltd Comparison of efficacy and safety of norgestimate-ethinylestradiol and cyproterone acetate-ethinylestradiol in the treatment of acne vulgaris http:\/\/clinicaltrials.gov\/show\/NCT00752635"},{"key":"10.1111\/bjd.13681-BIB0065|bjd13681-cit-0065","first-page":"547","article-title":"Reduced estrogen ovulation inhibitor in acne therapy. Double-blind study comparing Diane-35 to Diane","volume":"104","author":"Aydinlik","year":"1986","journal-title":"Fortschr Med"},{"key":"10.1111\/bjd.13681-BIB0066|bjd13681-cit-0066","first-page":"590","article-title":"The comparative efficacy and safety of Diane-35 versus Diane-50 in the treatment of moderate to severe acne and seborrhoea: 12-month results","volume":"1","author":"Fugere","year":"1988","journal-title":"Recent Res Gynecol Endocrinol"},{"key":"10.1111\/bjd.13681-BIB0067|bjd13681-cit-0067","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2230.1987.tb02499.x","article-title":"Efficacy of low-dose cyproterone acetate compared with minocycline in the treatment of acne vulgaris","volume":"12","author":"Monk","year":"1987","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.13681-BIB0068|bjd13681-cit-0068","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.sder.2008.06.002","article-title":"Hormonal therapy for acne","volume":"27","author":"George","year":"2008","journal-title":"Semin Cutan Med Surg"},{"key":"10.1111\/bjd.13681-BIB0069|bjd13681-cit-0069","first-page":"CD004425","article-title":"Combined oral contraceptive pills for treatment of acne","volume":"3","author":"Arowojolu","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/bjd.13681-BIB0070|bjd13681-cit-0070","first-page":"83","article-title":"Combined oral contraceptives for the treatment of acne: a practical guide","volume":"90","author":"Arrington","year":"2012","journal-title":"Cutis"},{"key":"10.1111\/bjd.13681-BIB0071|bjd13681-cit-0071","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.beem.2012.11.002","article-title":"Hormonal contraception and venous thromboembolism: an epidemiological update","volume":"27","author":"Plu-Bureau","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1111\/bjd.13681-BIB0072|bjd13681-cit-0072","unstructured":"Pharmacovigilance Working Party (PhVWP) May 2011 plenary meeting http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2011\/05\/WC500106708.pdf"},{"key":"10.1111\/bjd.13681-BIB0073|bjd13681-cit-0073","unstructured":"European Medicines Agency Ethinylestradiol-Drospirenone 24\u00a0+\u00a04, 19 April 2012 http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/referrals\/Ethinylestradiol-Drospirenone\/human_referral_000308.jsp&mid=WC0b01ac05805c516f"},{"key":"10.1111\/bjd.13681-BIB0074|bjd13681-cit-0074","unstructured":"European Medicines Agency Benefits of Diane 35 and its generics outweigh risks in certain patient groups - PRAC recommendation endorsed by CMDh, May 2013 http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2013\/05\/news_detail_001801.jsp&mid=WC0b01ac058004d5c1"},{"key":"10.1111\/bjd.13681-BIB0075|bjd13681-cit-0075","doi-asserted-by":"crossref","first-page":"f4932","DOI":"10.1136\/bmj.f4932","article-title":"European Commission orders France to lift ban on acne pill","volume":"347","author":"Arie","year":"2013","journal-title":"BMJ"},{"key":"10.1111\/bjd.13681-BIB0076|bjd13681-cit-0076","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1067\/mjd.2002.120448","article-title":"Oral contraceptive efficacy and antibiotic interaction: a myth debunked","volume":"6","author":"Archer","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13681-BIB0077|bjd13681-cit-0077","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0010-7824(99)00009-8","article-title":"Interaction between broad-spectrum antibiotics and the combined oral contraceptive pill. A literature review","volume":"59","author":"Weaver","year":"1999","journal-title":"Contraception"},{"key":"10.1111\/bjd.13681-BIB0078|bjd13681-cit-0078","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0190-9622(97)80322-2","article-title":"Oral contraceptive failure rates and oral antibiotics","volume":"36","author":"Helms","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13681-BIB0079|bjd13681-cit-0079","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archderm.1994.01690030128027","article-title":"Frequency of pregnancy in acne patients taking oral antibiotics and oral contraceptives (letter)","volume":"130","author":"London","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13681-BIB0080|bjd13681-cit-0080","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1067\/mjd.2002.126823","article-title":"Drug interaction: proteins, pumps, and P-450s","volume":"47","author":"Shapiro","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13681-BIB0081|bjd13681-cit-0081","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.3748\/wjg.v12.i46.7551","article-title":"Hepatotoxicity induced by cyproterone acetate: a report of three cases","volume":"12","author":"Savidou","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1111\/bjd.13681-BIB0082|bjd13681-cit-0082","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1523-1747.2001.01312.x","article-title":"Sebocytes are the key regulators of androgen homeostasis in human skin","volume":"116","author":"Fritsch","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13681-BIB0083|bjd13681-cit-0083","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF00455168","article-title":"Effect of cyproterone acetate-ethinylestradiol treatment on the proportion of linoleic acid and sebaleic acid in various skin surface lipid classes","volume":"278","author":"Stewart","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/bjd.13681-BIB0084|bjd13681-cit-0084","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1211357","article-title":"Experience in the long-term treatment of patients with hirsutism and\/or acne with cyproterone acetate-containing preparations: efficacy, metabolic, and endocrine effects","volume":"103","author":"Wayjen","year":"1995","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1111\/bjd.13681-BIB0085|bjd13681-cit-0085","first-page":"157","article-title":"Efficacit\u00e9 de l'acetate de cyproterone oral associ\u00e9 \u00e0 l'ethinylestradiol dans le traitement de l'acn\u00e9 tardive de type facial","volume":"60","author":"Gollnick","year":"1999","journal-title":"Ann Endocrinol"},{"key":"10.1111\/bjd.13681-BIB0086|bjd13681-cit-0086","first-page":"142","article-title":"L'acn\u00e9: Les traitements hormonaux","volume":"130","author":"Faure","year":"2003","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/bjd.13681-BIB0087|bjd13681-cit-0087","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00003495-200363050-00003","article-title":"Progesterons with antiandrogenic properties","volume":"63","author":"Raudrant","year":"2003","journal-title":"Drugs"},{"key":"10.1111\/bjd.13681-BIB0088|bjd13681-cit-0088","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0015-0282(16)59346-7","article-title":"The endocrine effects of spironolactone as an antiandrogen","volume":"48","author":"Young","year":"1987","journal-title":"Fertil Steril"},{"key":"10.1111\/bjd.13681-BIB0089|bjd13681-cit-0089","first-page":"37","article-title":"Oral spironolactone in post-teenage female patients with acne vulgaris","volume":"5","author":"Kim","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1111\/bjd.13681-BIB0090|bjd13681-cit-0090","first-page":"CD000194","article-title":"Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne","volume":"2","author":"Brown","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/bjd.13681-BIB0091|bjd13681-cit-0091","first-page":"422","volume-title":"Comprehensive Dermatologic Drug Therapy","author":"Wolverton","year":"2007","edition":"2"},{"key":"10.1111\/bjd.13681-BIB0092|bjd13681-cit-0092","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/1523-1747.ep12472325","article-title":"Spironolactone directly inhibits proliferation of cultured human facial sebocytes and acts antagonistically to testosterone and 5-alpha-dihydrotestosterone in vitro","volume":"100","author":"Akamatsu","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13681-BIB0093|bjd13681-cit-0093","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2007.09.024","article-title":"Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone","volume":"58","author":"Krunic","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13681-BIB0094|bjd13681-cit-0094","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1046\/j.1365-2133.2003.05369.x","article-title":"Congenital adrenal hyperplasia and acne in male patients","volume":"148","author":"Degitz","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13681-BIB0095|bjd13681-cit-0095","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3109\/09513590.2010.526664","article-title":"Retrospective, observational study on the effects and tolerability of flutamide in a large population of patients with acne and seborrhea over a 15-year period","volume":"27","author":"Paradisi","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1111\/bjd.13681-BIB0096|bjd13681-cit-0096","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/CCID.S20543","article-title":"Flutamide versus a cyproterone acetate-ethinyl estradiol combination in moderate acne: a pilot randomized clinical trial","volume":"4","author":"Adalatkhah","year":"2011","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1111\/bjd.13681-BIB0097|bjd13681-cit-0097","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1210\/jc.2006-2798","article-title":"Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: a 12-month, double-blind, parallel clinical trial","volume":"92","author":"Calaf","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/bjd.13681-BIB0098|bjd13681-cit-0098","first-page":"423","article-title":"Low dose flutamide in the treatment of acne vulgaris in women with or without oligomenorrhea or amenorrhea","volume":"22","author":"Wang","year":"1999","journal-title":"Changgeng Yi Xue Za Zhi"},{"key":"10.1111\/bjd.13681-BIB0099|bjd13681-cit-0099","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0015-0282(16)56518-2","article-title":"Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial","volume":"61","author":"Cusan","year":"1994","journal-title":"Fertil Steril"},{"issue":"3 Pt 1","key":"10.1111\/bjd.13681-BIB0100|bjd13681-cit-0100","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0190-9622(90)70241-9","article-title":"Treatment of hirsutism with the pure antiandrogen flutamide","volume":"23","author":"Cusan","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13681-BIB0101|bjd13681-cit-0101","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2265.1993.tb01768.x","article-title":"The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism","volume":"39","author":"Couzinet","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/bjd.13681-BIB0102|bjd13681-cit-0102","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0020-7292(91)90772-W","article-title":"Flutamide in the treatment of hirsutism","volume":"36","author":"Motta","year":"1991","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1111\/bjd.13681-BIB0103|bjd13681-cit-0103","first-page":"1357","article-title":"Low-dose flutamide in the treatment of hyperandrogenism in adolescents","volume":"60","author":"Pizzo","year":"2008","journal-title":"Minerva Pediatr"},{"key":"10.1111\/bjd.13681-BIB0104|bjd13681-cit-0104","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/BF03348907","article-title":"Treatment with a gonadotropin-releasing-hormone agonist in acne and idiopathic hirsutism","volume":"16","author":"Faloia","year":"1993","journal-title":"J Endocrinol Invest"},{"issue":"Suppl. 1","key":"10.1111\/bjd.13681-BIB0105|bjd13681-cit-0105","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1111\/j.1610-0387.2009.07171.x","article-title":"Hormonelle Antiandrogene in der Aknetherapie","volume":"8","author":"Zouboulis","year":"2010","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.13681","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.13681\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T21:10:14Z","timestamp":1717708214000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/172\/S1\/37\/6615724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,19]]},"references-count":105,"URL":"https:\/\/doi.org\/10.1111\/bjd.13681","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6,19]]}}}